-
Honda accelerates its electrification layout in China, with joint ventures intensively deploying electric vehicles
To be honest, our current situation in China is indeed very difficult. The market competition is very fierce now. Guangzhou Honda used to focus more on the field of fuel vehicles. Now, 50% of China's ... -
A sharp drop of 87%! Maserati will only sell over 30 units in China in September! Has the 'Sports Car Queen' fallen from grace?
The intense competition in the car market has made even ultra luxury car brands unable to withstand it. Recently, the National Passenger Car Market Information Joint Conference released statistical d ... -
AbbVie Dual Anti Cancer New Drug Declares for Market in China
On November 6th, the latest announcement on the official website of the Center for Drug Evaluation (CDE) of the National Medical Products Administration stated that AbbVie's application for the launc ... -
Pfizer's innovative targeted therapy drug Taizena has been approved in China
The reporter learned that Pfizer's innovative drug for treating prostate cancer, Terzena& reg; （TALZENNA®， The generic name: Terazopanib Tosylate Capsules was approved by the National Medical P ... -
This US funded enterprise has clarified its confidence and direction for development in China through the CIIE
Shanghai, November 3 (Xinhua) - Boston Scientific, a US funded medical device company, recently announced two news in Shanghai. Firstly, its first production and manufacturing base in China has been ... -
Dialogue with Meng Pu, Chairman of Qualcomm China: Qualcomm has long-term accumulation in China and will adhere to the path of self-developed chips
At last week's Snapdragon Summit, Qualcomm released the new generation Snapdragon 8 Elite mobile platform and two brand new in car platforms. After the annual event, Meng Pu, Chairman of Qualcomm Chi ... -
When will Apple AI be launched in China? Cook responds!
According to Interface News, on October 23rd, Tim Cook, CEO of Apple Inc. (AAPL, stock price $235.86, market value $3.6 trillion), responded to a reporter's question during a visit to Weibo about whe ... -
The Boston Science Harbor Base has been completed and opened, achieving "independent production" in China
On October 15th, the first production and manufacturing base of Boston Scientific China, the Boston Scientific Port Base, was completed and opened, focusing on the production of medical consumables a ... -
Hyatt Hotels and China Resources Land establish a joint venture for light asset expansion, continuing to expand into the Chinese market
Reporter Shu Dongni On October 15th, Hyatt Hotels, an international hotel group, announced the establishment of a joint venture company, Runkai Holdings Limited, with China Resources Land, and signed ... -
Has the 'fixed price' policy been effective? General Motors' sales in China increased by 14.3% month on month in the third quarter, and SAIC GM's orders for certain models were overstocked
Recently, General Motors disclosed that in the third quarter of this year, the sales of cars by General Motors and its joint ventures in China exceeded 426000 units, a year-on-year decrease of 21%, b ... -
General Motors Q3 sold over 420000 vehicles in China, surpassing gasoline powered vehicles for the first time in new energy vehicles
China Economic Net, October 10th (Reporter Jiang Zhiwen) General Motors released data today showing that in the third quarter of this year, its retail sales in the Chinese market exceeded 420000 vehi ... -
Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
On September 27th, Sanofi announced that Dapitumab Injection has been approved by the China National Medical Products Administration for use in adult patients with chronic obstructive pulmonary disea ... -
The targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
Southern Finance and Economics, September 27th - Sanofi announced that Dabitou& reg; Dupilumab injection has been approved by the National Medical Products Administration (NMPA) of China for use in a ... -
Sanofi's targeted therapy drug for chronic obstructive pulmonary disease, Dabitou, has been approved in China
On September 27th, Sanofi announced that Dapitumab Injection has been approved by the China National Medical Products Administration for use in adult patients with chronic obstructive pulmonary disea ... -
Tianjing Biotechnology grants Sanofi the rights to Yulelimab in China with a down payment of 250 million yuan
Beijing News Tianjing Biotech announced on its official WeChat official account on September 25 that it had reached strategic cooperation with Sanofi on the development, production and commercializat ... -
Mercedes Benz invests another 14 billion yuan to deepen its layout in China and enrich its "Made in China" product lineup with "Chinese speed"
Mercedes Benz invests another 14 billion yuan to deepen its layout in China and enrich its "Made in China" product lineup at a "Chinese speed". On September 4th, Ola Klenius, Chairman of the Board of ... -
It is reported that Tesla plans to start producing a six seater version of the Model Y in China by the end of 2025
According to sources, Tesla plans to start producing the six seater version of the Model Y in China by the end of 2025. -
General Motors China responds to rumors of layoffs and capacity cuts: all business in China is high-quality assets
Recently, it was reported that General Motors is cutting personnel in relevant departments in the Chinese market, including the research and development department. In the coming weeks, General Motor ... -
Pfizer's new hemophilia treatment drug Mataximab's application for market launch in China has been accepted
On August 13th, the official website of the Drug Evaluation Center (CDE) of the China National Medical Products Administration (NMPA) announced that the Class 1 therapeutic biological product Mataxim ... -
Starbucks needs to find partners as revenue in China declines year-on-year
Starbucks is facing increasing growth pressure. On July 31st, the company released its performance for the third quarter of fiscal year 2024 (ending on June 30th, 2024). According to the financial re ...